By ipomarket.in Editorial Team · Last reviewed: 2026-11-19
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
Jerai Fitness Limited, a Mumbai-based manufacturer of fitness equipment, has cleared a key regulatory step towards a stock market listing. SEBI approved the company's IPO on December 31, 2025, roughly three months after Jerai filed its Draft Red Herring Prospectus (DRHP) on September 29, 2025.
Here is a plain reading of what the offer document tells us, and just as importantly, what has not been decided yet.
What is the Jerai Fitness IPO?
The proposed issue is a 100% Offer for Sale (OFS) of 43,92,500 equity shares. Each share has a face value of ₹10. An OFS means existing shareholders are selling part of their stake; the company itself receives no fresh capital from the issue. In Jerai's case there is no fresh issue component at all.
If you are new to this structure, our explainer on fresh issue vs OFS and where IPO money goes covers why this distinction matters. In a pure OFS, the proceeds go to the selling shareholders rather than funding the company's expansion or debt reduction.
Promoters Rajesh Ramsukh Rai and Rinku Rajesh Rai currently hold 100% of the company's equity, so the shares on offer will come from their holdings.
Company background
Jerai Fitness was incorporated in 1994 and operates out of Mumbai. It manufactures strength training and cardiovascular equipment and sells across both domestic and international markets.
The revenue split is heavily tilted towards the home market. In FY 2025, 92.30% of revenue came from domestic sales and 7.70% from exports. That makes it largely a play on Indian demand for gym and fitness equipment, with exports a smaller contributor.
Financials at a glance
Based on Ind AS figures disclosed in the offer document for the year ended 31 March 2025:
| Metric | FY25 |
|---|---|
| Revenue | ₹1,280.46 million (₹128.05 crore) |
| Profit after tax | ₹234.01 million (₹23.40 crore) |
| Net worth | ₹1,045.65 million (₹104.57 crore) |
| Return on Net Worth (RoNW) | 25.19% |
A RoNW of 25.19% indicates the company generated healthy returns on the equity capital it employed in FY25. RoNW measures profit after tax as a share of net worth. These are single-year figures; a reviewer should look at the multi-year trend in the DRHP before drawing conclusions about consistency.
The profit margin in FY25 works out to roughly 18% of revenue (₹23.40 crore PAT on ₹128.05 crore revenue), which is a derived figure based on the two reported numbers.
Issue details, intermediaries and listing
Emkay Global Financial Services Ltd. is the book running lead manager (BRLM) for the issue, and Bigshare Services Pvt. Ltd. is the registrar. The shares are proposed to be listed on both the NSE and BSE.
The registrar handles allotment and refunds once the issue closes. If you want to understand how that works, see our guide to the IPO allotment process.
What is not confirmed yet
This is where caution is warranted. Several details that retail investors typically wait for have not been announced:
- IPO opening and closing dates are yet to be announced.
- The price band is yet to be announced.
- The grey market premium (GMP) is not disclosed or available.
Without a price band, it is not possible to calculate the issue size in rupees, the implied valuation, or any per-share metrics. Any figure circulating for these is speculation until the company files its Red Herring Prospectus with final terms.
On GMP specifically, remember that grey market numbers are unofficial and unregulated. Our primer on what IPO GMP is and how it works explains why it is a weak basis for decisions even when it is available, let alone when it is not.
How to read this stage
SEBI approval is a procedural clearance that the DRHP meets disclosure norms. It is not an endorsement of the company or its pricing. Many companies receive approval and then wait months before launching, and some do not launch at all.
For Jerai, the business fundamentals in FY25 look solid on the reported numbers, but the entire investment case hinges on pricing that is not yet public. A reasonable analysis is impossible until the price band and dates arrive.
FAQ
When is the Jerai Fitness IPO date?
The opening and closing dates are yet to be announced. SEBI approved the IPO on December 31, 2025, but the company has not released a launch date. Watch our upcoming IPOs list for updates.
What is the Jerai Fitness IPO price band?
The price band has not been announced yet. It will be disclosed closer to the launch when the company files its Red Herring Prospectus with final terms.
Is the Jerai Fitness IPO a fresh issue or OFS?
It is a 100% Offer for Sale of 43,92,500 equity shares, with no fresh issue. The proceeds go to the selling promoters, not the company.
What were Jerai Fitness's FY25 financials?
For the year ended 31 March 2025, the company reported revenue of ₹128.05 crore, profit after tax of ₹23.40 crore, net worth of ₹104.57 crore and RoNW of 25.19%.
Is there a GMP for the Jerai Fitness IPO?
No. The grey market premium is not disclosed or available at this stage, which is expected given that the price band and dates have not been set.
Last reviewed: 2026-11-19. Figures are drawn from the company's DRHP and public filings; please verify against the final offer document before acting.